Víctor Jiménez‐Yuste

9.8k total citations · 5 hit papers
266 papers, 5.8k citations indexed

About

Víctor Jiménez‐Yuste is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, Víctor Jiménez‐Yuste has authored 266 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 241 papers in Hematology, 73 papers in Genetics and 26 papers in Surgery. Recurrent topics in Víctor Jiménez‐Yuste's work include Hemophilia Treatment and Research (199 papers), Platelet Disorders and Treatments (98 papers) and Blood Coagulation and Thrombosis Mechanisms (65 papers). Víctor Jiménez‐Yuste is often cited by papers focused on Hemophilia Treatment and Research (199 papers), Platelet Disorders and Treatments (98 papers) and Blood Coagulation and Thrombosis Mechanisms (65 papers). Víctor Jiménez‐Yuste collaborates with scholars based in Spain, Italy and Germany. Víctor Jiménez‐Yuste's co-authors include E. Carlos Rodríguez‐Merchán, F. Hernández‐Navarro, Ana Villar, Johannes Oldenburg, Hortensia De la Corte‐Rodríguez, Midori Shima, Christophe Schmitt, Julio Delgado, Gallia G. Levy and Elena Santagostino and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Víctor Jiménez‐Yuste

251 papers receiving 5.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors

2018 503 citations Johnny Mahlangu, Johannes Oldenburg et al. profile →
Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study

2019 273 citations Steven W. Pipe, Midori Shima et al. profile →
A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors

2019 263 citations Guy Young, Ri Liesner et al. Blood profile →
International recommendations on the diagnosis and treatment of acquired hemophilia A

2020 183 citations Andreas Tiede, Jerome Teitel et al. profile →
Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A

2023 100 citations Pratima Chowdary, Johannes Oldenburg et al. profile →

Peers

Countries citing papers authored by Víctor Jiménez‐Yuste

Since Specialization

Citations

This map shows the geographic impact of Víctor Jiménez‐Yuste's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Víctor Jiménez‐Yuste with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Víctor Jiménez‐Yuste more than expected).

Fields of papers citing papers by Víctor Jiménez‐Yuste

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Víctor Jiménez‐Yuste. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Víctor Jiménez‐Yuste. The network helps show where Víctor Jiménez‐Yuste may publish in the future.

Co-authorship network of co-authors of Víctor Jiménez‐Yuste

This figure shows the co-authorship network connecting the top 25 collaborators of Víctor Jiménez‐Yuste. A scholar is included among the top collaborators of Víctor Jiménez‐Yuste based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Víctor Jiménez‐Yuste. Víctor Jiménez‐Yuste is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Marstacimab prophylaxis in hemophilia A/B without inhibitors: results from the phase 3 BASIS trial 2025 ·Blood ·Davide Matino, Andrew Palladino, Carrie Turich Taylor, Eunhee Hwang, Sangeeta Raje, Satyaprakash Nayak, (unknown), Suchitra S. Acharya, Johnny Mahlangu, Víctor Jiménez‐Yuste, (unknown), (unknown), Chi Kong Li, Murtadha Al‐Khabori, Yasser Wali, (unknown), Young Shil Park, Bülent Zülfikar, John G. Teeter	3
2	Arthroscopic ankle surgery in people with haemophilia 2024 ·Haemophilia ·E. Carlos Rodríguez‐Merchán, Hortensia De la Corte‐Rodríguez, Primitivo Gómez-Cardero, María Román, Víctor Jiménez‐Yuste	1
3	Value contribution of etranacogene dezaparvovec gene therapy in moderately severe and severe haemophilia B through multi‐criteria decision analysis 2024 ·Haemophilia ·(unknown), Xavier Badía, (unknown), Víctor Jiménez‐Yuste, (unknown), Ramiro Núñez, José Luís Poveda, José Luís Trillo, (unknown)	1
4	Low Plasma Levels of Hyaluronic Acid Might Rule Out Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation 2023 ·Disease Markers ·(unknown), (unknown), (unknown), (unknown), Ana López de la Guía, Raquel de Paz, Mercedes Gasior Kabat, (unknown), (unknown), Miguel Canales, Nora Butta, Víctor Jiménez‐Yuste	1
5	Complications and Implant Survival of Total Knee Arthroplasty in People with Hemophilia 2022 ·Journal of Clinical Medicine ·E. Carlos Rodríguez‐Merchán, Hortensia De la Corte‐Rodríguez, (unknown), Primitivo Gómez-Cardero, (unknown), Víctor Jiménez‐Yuste	3
6	Development of a telematic pharmaceutical care app (Haemoassist) for multidisciplinary follow-up of patients with congenital coagulopathies 2022 ·Expert Review of Hematology ·(unknown), (unknown), (unknown), (unknown), María Román, Víctor Jiménez‐Yuste, Mónica Martín‐Salces, Hortensia De la Corte‐Rodríguez, (unknown), Juana Benedı́, E. Carlos Rodríguez‐Merchán	2
7	Total knee arthroplasty in hemophilia: lessons learned and projections of what’s next for hemophilic knee joint health 2022 ·Expert Review of Hematology ·E. Carlos Rodríguez‐Merchán, Hortensia De la Corte‐Rodríguez, (unknown), Primitivo Gómez-Cardero, (unknown), Víctor Jiménez‐Yuste	6
8	Arthropathy in people with mild haemophilia: Exploring risk factors 2022 ·Thrombosis Research ·Hortensia De la Corte‐Rodríguez, E. Carlos Rodríguez‐Merchán, María Román, Mónica Martín‐Salces, (unknown), Víctor Jiménez‐Yuste	12
9	Clinical assessment and point of care ultrasonography: How to diagnose haemophilic synovitis 2021 ·Haemophilia ·Hortensia De la Corte‐Rodríguez, E. Carlos Rodríguez‐Merchán, María Román, Mónica Martín‐Salces, Víctor Jiménez‐Yuste	14
10	The effect of emicizumab prophylaxis on long‐term, self‐reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies 2021 ·Haemophilia ·Mark W. Skinner, Claude Négrier, Ido Paz‐Priel, Sammy Chebon, Víctor Jiménez‐Yuste, Michael U. Callaghan, Michaela Lehle, Markus Niggli, Johnny Mahlangu, Amy D. Shapiro, Midori Shima, Avrita Campinha‐Bacote, Gallia G. Levy, Johannes Oldenburg, Sylvia von Mackensen, Steven W. Pipe	34
11	Post‐hoc analysis on the long‐term response to fixed‐dose prophylaxis with N8‐GP in patients with haemophilia A 2021 ·Haemophilia ·Andreas Tiede, K. K. Hampton, Víctor Jiménez‐Yuste, Guy Young, (unknown), Pratima Chowdary	0
12	Ultrasound evaluation of joint damage and disease activity in adult patients with severe haemophilia A using the HEAD‐US system 2021 ·Haemophilia ·Víctor Jiménez‐Yuste, Hortensia De la Corte‐Rodríguez, María Román, Mónica Martín‐Salces, Felipe Querol, Santiago Bonanad, María Eva Mingot‐Castellano, Nuria Fernández‐Mosteirín, (unknown), Amparo Santamaría, Ramiro Núñez, Luis J. Garcia‐Frade, Carlo Martinoli, Hae‐Kyung Kim	8
13	Diferencias en los parámetros de carga externa entre el pádel masculino y femenino profesional 2021 ·Journal of Sport and Health Research ·(unknown), Víctor Jiménez‐Yuste, (unknown), (unknown)	5
14	Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies 2020 ·Blood ·Michael U. Callaghan, Claude Négrier, Ido Paz‐Priel, Tiffany Chang, Sammy Chebon, Michaela Lehle, Johnny Mahlangu, Guy Young, Rebecca Kruse‐Jarres, Maria Elisa Mancuso, Markus Niggli, Monet Howard, Nives Selak Bienz, Midori Shima, Víctor Jiménez‐Yuste, Christophe Schmitt, Elina Asikanius, Gallia G. Levy, Steven W. Pipe, Johannes Oldenburg	170
15	Adherence to prophylaxis in adult patients with severe haemophilia A 2020 ·Haemophilia ·Santiago Bonanad, (unknown), José A. Aznar, María Eva Mingot‐Castellano, Víctor Jiménez‐Yuste, (unknown), Antonio Palma, María Fernanda López Fernández, Pascual Marco, (unknown), Nuria Fernández‐Mosteirín, (unknown), (unknown), (unknown)	3
16	Clinical evaluation of bleeds and response to haemostatic treatment in patients with acquired haemophilia: A global expert consensus statement 2019 ·Haemophilia ·Andreas Tiede, Paul Giangrande, Jerome Teitel, Kagehiro Amano, Gary Benson, László Nemes, Víctor Jiménez‐Yuste, Roseline d’Oiron, (unknown), Craig M. Kessler	27
17	Common themes and challenges in hemophilia care: a multinational perspective 2018 ·Hematology ·Jayson Stoffman, Nadine G. Andersson, Brian R. Branchford, Katharine Batt, Roseline d’Oiron, Carmen Escuriola Ettingshausen, (unknown), Víctor Jiménez‐Yuste, Kaan Kavaklı, Maria Elisa Mancuso, Keiji Nogami, (unknown), Renyi Wu	14
18	Tailoring care to haemophilia patients' needs: which specialty and when? 2015 ·PubMed ·Massimo Morfini, Gary Benson, Víctor Jiménez‐Yuste, Rolf Ljung, Pier Mannuccio Mannucci, Gianluigi Pasta, Eduardo Remor, Silva Zupančić Šalek	10
19	Inhibitor eradication therapy in non-severe hemophilia A 2013 ·Journal of Thrombosis and Haemostasis ·Alice S. van Velzen, Corien L. Eckhardt, Matthew Peters, (unknown), Savita Rangarajan, C. R. M. Hay, Maria Elisa Mancuso, Frans J. Smiers, Ri Liesner, Pia Petrini, Víctor Jiménez‐Yuste, Johanna G. van der Bom, (unknown), Thomas W. Yee	1
20	Induction of a Hypercoagulability State and Endothelial Cell Activation by Granulocyte Colony-Stimulating Factor in Peripheral Blood Stem Cell Donors 2002 ·Journal of Hematotherapy & Stem Cell Research ·Miguel Canales, (unknown), Rubén Gómez Rioja, Jesús Díez‐Manglano, Víctor Jiménez‐Yuste, F. Hernández‐Navarro	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact